Further Weakness as UroGen Pharma (NASDAQ:URGN) Drops 13% This Week, Taking Five-year Losses to 64%

Simply Wall StNov 18 19:14

UroGen Pharma Ltd. (URGN) Q3 2024 Earnings Call Transcript Summary

Futu NewsNov 7 06:21 · Conference Call

UroGen Pharma Ltd. (URGN) Q3 2024 Earnings Call Transcript

Earnings Call TranscriptsNov 7 06:12

TD Cowen Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Announces Target Price $35

Futu NewsNov 7 04:31 · Ratings

EF Hutton Maintains Buy on UroGen Pharma, Maintains $25 Price Target

Analyst UpgradesNov 7 00:19

UroGen Pharma Analyst Ratings

BenzingaNov 7 00:19 · Ratings